C.I. MedicalLtd Past Earnings Performance

Past criteria checks 1/6

C.I. MedicalLtd has been growing earnings at an average annual rate of 9.5%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 11.5% per year. C.I. MedicalLtd's return on equity is 10.4%, and it has net margins of 4.6%.

Key information

9.5%

Earnings growth rate

9.5%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate11.5%
Return on equity10.4%
Net Margin4.6%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

May 02
Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Apr 14
Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

Mar 08
Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18
Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31
Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13
Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26
Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08
Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20
Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On

Jul 07
The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On

Revenue & Expenses Breakdown
Beta

How C.I. MedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:3540 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2345,6282,0829,0040
30 Sep 2345,0712,1628,4520
30 Jun 2344,1252,2198,1320
31 Mar 2343,4732,1737,9310
31 Dec 2242,8912,5217,6810
30 Sep 2242,0732,7097,5330
30 Jun 2241,7542,7987,3580
31 Mar 2241,1422,8157,2420
31 Dec 2141,2052,8207,0810
30 Sep 2141,5003,1827,0410
30 Jun 2140,8333,3346,8720
31 Mar 2139,5933,3096,6220
31 Dec 2037,3932,9206,5900
30 Sep 2033,2512,2636,2600
30 Jun 2031,9641,9246,0930
31 Mar 2030,2651,6085,9590
31 Dec 1928,7631,5055,6530
30 Sep 1928,8761,5715,4750
30 Jun 1926,8981,3455,2680
31 Mar 1926,4841,4145,1120
31 Dec 1825,8061,3294,9450
30 Sep 1824,8921,3584,7570
30 Jun 1824,3231,4584,5230
31 Mar 1823,3361,4454,2630
31 Dec 1722,8301,5394,0880
30 Sep 1721,9991,4863,9320
30 Jun 1721,4401,4973,8810
31 Mar 1720,8871,3903,7940
31 Dec 1620,3341,2823,7060
31 Dec 1518,1451,0883,0790
31 Dec 1416,0849012,7120

Quality Earnings: 3540 has a high level of non-cash earnings.

Growing Profit Margin: 3540's current net profit margins (4.6%) are lower than last year (5.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 3540's earnings have grown by 9.5% per year over the past 5 years.

Accelerating Growth: 3540's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3540 had negative earnings growth (-17.4%) over the past year, making it difficult to compare to the Healthcare industry average (8.4%).


Return on Equity

High ROE: 3540's Return on Equity (10.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.